Delphia (USA)’s Teladoc Health TDOC Stock Holding History

Delphia (USA)’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-8,228	Closed	-$273K	–	417
2022 Q2	$273K	Buy	+8,228	New	+$349K	0.19%	198

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SOMRS

State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return

Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Delphia (USA)'s TDOC Position: Q3 2022 in Review

Delphia (USA) sold out of Teladoc Health (TDOC) in Q3 2022, closing a stake of 8,228 shares — an estimated $273K sold.

Delphia (USA) first reported a position in TDOC in Q2 2022 and held it in 1 quarter. The position peaked at $273K in Q2 2022. 482 funds tracked by Wall St. Rank hold TDOC as of Q3 2022.

Delphia (USA) reported no remaining Teladoc Health position as of Q3 2022 after selling out during the quarter.
Delphia (USA) sold 8,228 Teladoc Health shares in Q3 2022, an estimated $273K.
Delphia (USA) first reported a position in Teladoc Health in Q2 2022 and held it in 1 quarter.
Delphia (USA)'s Teladoc Health position peaked at $273K in Q2 2022.
482 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2022.

Based on Delphia (USA)'s 13F filing for Q3 2022, filed 14 Nov 2022.